Transcatheter Valves: Tough Love For Transapical Placement Method At TCT
This article was originally published in The Gray Sheet
Executive Summary
Alternative technique for inserting transcatheter aortic heart valves was the subject of multiple reports of subpar data last week.
You may also be interested in...
Micro Interventional Preps 2013 EU Launch For Transapical Access Device
Privately held Micro Interventional Devices hopes to meet a growing demand for adjunct devices for transapical heart valve replacement.
Micro Interventional Devices: Creating A Tool Box For Structural Heart Disease
Micro Interventional Devices was founded around opportunities in addressing the procedural challenges that limit patient access to transcatheter heart valves. The company’s initial focus is on developing a transcatheter valve for the replacement of the mitral valve, and an easy and effective transapical access and closure method for transcatheter mitral and aortic valve procedures. The company’s mission, though, is to broadly focus on advancing structural heart disease treatments, and MID’s first-generation technology has potential application to several areas of structural heart disease, including PFO/atrial septal defect closure, left atrial appendage closure and cardiac ablations.
Sapien Heart Valve Gets FDA Panel Nod For High-Risk Surgical Patients
Edwards Lifesciences’ first-to-market transcatheter valve is safe and effective, and its benefits outweigh its risks in an expanded patient population, an FDA advisory panel says.